Results 11 to 20 of about 6,119,378 (259)

Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient

open access: yesInternational Journal of Infectious Diseases, 2015
The duration of a protective level of yellow fever antibodies after autologous hematopoietic stem cell transplantation in a previously vaccinated person is unclear.
Kayoko Hayakawa   +10 more
doaj   +2 more sources

Hematopoietic stem cell transplantation for the management of follicular lymphoma

open access: yesStem Cells and Cloning: Advances and Applications, 2010
Chitra HosingDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USAAbstract: Although much has been published on the application of autologous and allogeneic hematopoietic ...
Chitra Hosing
doaj   +1 more source

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis

open access: yesHematology
To evaluate whether patients with multiple myeloma (MM) could benefit from tandem autologous hematopoietic stem cell transplantation (auto-HSCT), PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched, and 10 eligible ...
Hongtao Li   +3 more
doaj   +2 more sources

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis

open access: yesAnnals of Indian Academy of Neurology, 2015
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell ...
Awadh Kishor Pandit   +2 more
doaj   +2 more sources

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases [PDF]

open access: yesActa Haematologica, 2005
Ten years have passed since the first published consensus statement on the use of hematopoietic stem cell transplantation (HSCT) in the treatment of severe autoimmune disease (AD) appeared. During that time, around 700 patients suffering from severe AD have undergone HSCT in the frame of phase I/II clinical trials from over 20 countries including the ...
Tyndall A, Daikeler T
openaire   +8 more sources

Optimizing Autologous Hematopoietic Stem Cell Transplantation for Acute Leukemia [PDF]

open access: yesStem Cells Translational Medicine, 2021
Abstract Autologous hematopoietic stem cell transplantation (ASCT) remains an important postremission treatment for acute leukemia (AL). It is known that some prognostic factors, such as age, cytogenetic and molecular risk stratification, and minimal residual disease (MRD) status, are closely related to clinical outcomes following ASCT ...
Aiming Pang   +6 more
openaire   +3 more sources

Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma [PDF]

open access: yes, 2003
High-dose chemotherapy with autologous peripheral blood stem cell transplantation is the standard treatment of patients with multiple myeloma today. In this study we used a combination mobilizing chemotherapy containing ifosfamide with G-CSF before stem ...
Werding, N.   +5 more
core   +2 more sources

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study [PDF]

open access: yes, 2013
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro   +31 more
core   +1 more source

Autologous hematopoietic stem cell transplantation (auto-HSCT) in children in Poland: 2021 indications and practice [PDF]

open access: yes, 2021
Unlike in adults, the number of pediatric autologous hematopoietic stem cell transplants (HSCT) has decreased in last years. This is because of changing indications for this type of treatment and new therapies available in recent years.
Drabko, Katarzyna; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland
core   +1 more source

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor [PDF]

open access: yes, 2013
Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation.
Dembowsky, K.   +38 more
core   +1 more source

Home - About - Disclaimer - Privacy